Announcements Trials
Browse Landscape

Phase

Phase 2 126Phase 1 83Phase 1/2 48Phase 3 33Phase NA 12Phase 4 7Phase 2/3 3Phase EARLY_PHASE1 1

Status

Recruiting 3Completed 3Terminated 2Not yet recruiting 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Myeloid 1

Conditions

Recurrence 1Lymphoma, Mantle-Cell 1Lymphoma 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Cisplatin 22Fluorouracil 21Radiotherapy 18Gemcitabine 17Docetaxel 16Oxaliplatin 15Paclitaxel 14Carboplatin 13Capecitabine 13Bevacizumab 13Leucovorin 11Cyclophosphamide 11Irinotecan 10Drug Therapy 10Cytarabine 9Saline Solution 7Magnetic Resonance Spectroscopy 7Letrozole 7Dexamethasone 7Rituximab 6Nivolumab 6Methotrexate 6Exercise 6Etoposide 6Electroporation 6Doxorubicin 6pembrolizumab 5Pemetrexed 5Metformin 5Melphalan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Completed × fludarabine × Clear all
NCT02707393 2021-04-15

Allogeneic Stem Cell Transplantation for Children With CML

St. Anna Kinderkrebsforschung

Phase 2/3 Completed
13 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00641095 2018-10-31

MCLPIII

University College, London

Phase 2/3 Completed
370 enrolled
Lymphoid

Lymphoma, Lymphoma, Mantle-Cell

NCT01423032 2011-08-25

Bendamustine Versus Fludarabine in Chronic Lymphocytic Leukemia (CLL)

WiSP Wissenschaftlicher Service Pharma GmbH

Phase 2/3 Completed
96 enrolled
LymphoidOther hematologic neoplasm

Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡